Wells Fargo Starts Medpace (MEDP) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Wells Fargo Starts Medpace (MEDP) at Outperform
September 6, 2016 8:02 AM EDT
William Blair initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
...
More
September 6, 2016 7:08 AM EDT
Credit Suisse initiates coverage on Medpace (NASDAQ: MEDP) with a Outperform rating and a price target of $35.00.
Analyst Erin Wilson commented, "MEDP is a leading global clinical stage contract research organization (CRO), differentiated in its exclusively full-service model. It should benefit from a... More
September 6, 2016 6:56 AM EDT
Baird initiated coverage on Medpace (NASDAQ: MEDP) with a Neutral rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
...
More
September 6, 2016 6:46 AM EDT
Jefferies initiates coverage on Medpace (NASDAQ: MEDP) with a Hold rating and a price target of $32.50.
Analyst David Windley commented, "We initiate on MEDP with a $32.50 PT and Hold rating on valuation (+33.5% since pricing). MEDP competes in the phase I-IV CRO space, wins mandates... More
September 6, 2016 6:42 AM EDT
UBS initiated coverage on Medpace (NASDAQ: MEDP) with a Buy rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
...
More
